PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 140 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,900,000 | -96.3% | 9,400 | -98.6% | 0.10% | -97.9% |
| Q3 2017 | $78,781,000 | +165.9% | 657,876 | +94.1% | 4.97% | +178.9% |
| Q2 2017 | $29,628,000 | +818.7% | 338,994 | +291.0% | 1.78% | +682.0% |
| Q1 2017 | $3,225,000 | -92.2% | 86,700 | -78.4% | 0.23% | -80.6% |
| Q4 2013 | $41,550,000 | +132.7% | 401,330 | +20.6% | 1.17% | +162.1% |
| Q3 2013 | $17,858,000 | -45.9% | 332,791 | -55.3% | 0.45% | -42.0% |
| Q2 2013 | $33,029,000 | – | 744,403 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |